F/m Emerald Life Sciences Innovation ETF
1251 Capital Group, Inc. LFSC ETF
| LFSC Price | $21.8987 |
Market Cap | $50.79M |
| Annual Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
| Yearly Management Fee | 0.54% |
Asset Class | Equity |
| Focus | Health care |
Category | Sector, Health Care |
| Niche | Pharma, biotech & life sciences |
Last 24h Volume | $972 |
| Portfolio Management Company | 1251 Capital Group, Inc. |
Discount/Premium to NAV | 0.09% |
| Inception Date | Oct 30, 2024 |
Market Cap Rank | 2529 |
| Monthly AUM Growth | -3.63% |
Holdings Region | North America |
| Management Style | Active |
Leverage | Non-Leveraged |
F/m Emerald Life Sciences Innovation ETF is an ETF issued by 1251 Capital Group, Inc. on Oct 30 2024.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of LFSC ETF according to its net asset value is premiumed at 0.09%.
While the total value of the fund shows $-1,912,287 decrease compared to the previous month, its price is traded daily at a decrease of -2.46%.
The annual dividend yield of LFSC ETF is 0.00%, whereas its main asset area is North America.
LFSC ETF, whose 24-hour total volume is $972, has experienced a $1.67M cash inflow in the last month.
In addition, F/m Emerald Life Sciences Innovation ETF's net asset value total return is 0.00%.
LFSC ETF Returns
| Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
| -2.46% |
-7.01% |
-8.68% |
-6.97% |
-12.48% |
-7.76% |
-12.48% |
LFSC ETF NAV Total Return
| Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
| -8.62% |
-4.07% |
-4.07% |
-4.07% |
-4.07% |
-4.07% |
LFSC ETF Fund Flows Chart
LFSC ETF Market Cap Chart
LFSC ETF NAV Growth Chart
LFSC ETF Comments
no comments yet